A large study of more than 1 million matched patient pairs has found that serious infections across the body are followed by increased risks of psychiatric and neurological diagnoses, especially in adults.
Findings from the landmark Articulate Pro study have now been published, marking a major milestone for the use of artificial intelligence (AI) in NHS histopathology laboratories and demonstrating its potential to improve and standardise prostate cancer diagnosis.
The University of Oxford\u2019s Oxford Vaccine Group has launched the world\u2019s first Phase I clinical trial, BD-Ebov, of a vaccine against Bundibugyo ebolavirus (BDBV), in response to the ongoing outbreak in the Democratic Republic of the Congo and neighbouring Uganda.
An analysis of nearly three decades of mortality data in the United States of America (USA) published in Nature Health has found that cigarette smoking accounted for nearly two-thirds of excess deaths among White Americans with lower levels of education.
Conducting the first-ever, large-scale analysis of Pharmacy First consultations in GP records, researchers at the Bennett Institute for Applied Data Science, London School of Hygiene and Tropical Medicine, University of Nottingham, University of Manchester, and UKHSA used OpenSAFELY to analyse the programme\u2019s service uptake, data quality, and integration into primary care systems.
A clinical study at the University of Oxford has recruited its first participant, marking the world\u2019s first successful transplantation of a perfused human pancreas and a major advance in efforts to improve organ preservation for transplantation.
The European Patent Office (EPO) has awarded Professor Sir Adrian Hill the European Inventor Award 2026 in the Research category for developing the R21/Matrix-M malaria vaccine.
The Sagittarius Team, a pioneering partnership between the University of Oxford and Oxford University Hospitals (OUH) has been recognised with the OUH Award for Excellence 2026 for transforming care for people experiencing a relapse of ulcerative colitis while advancing translational research.
Professor Kokila Lakhoo, Professor of Paediatric Surgery in the Nuffield Department of Surgical Sciences (NDS), University of Oxford, has been awarded the Denis Browne Gold Medal, the highest honour bestowed by the British Association of Paediatric Surgeons (BAPS). The award recognises outstanding lifetime contributions to paediatric surgery worldwide and is presented annually at the Association's Annual Congress.
Patient enrolment has begun in the Democratic Republic of the Congo for the PARTNERS clinical trial of treatments for Bundibugyo virus disease (BVD). The trial is led in the DRC by the Institute National pour la Recherche Biomedicale, supported by the Institute of Tropical Medicine in Belgium, Ministry of Public Health of the Democratic Republic of the Congo, ALIMA (The Alliance for International Medical Action) and outbreak response teams from M\u00e9decins Sans Fronti\u00e8res (MSF). \r\n\r\nInternational trial coordination is led by the Pandemic Sciences Institute at the University of Oxford.
Three University of Oxford academics have become the latest to join the eminent life scientists in Europe and beyond that make up the European Molecular Biology Organization (EMBO).
A major new research and engagement programme at the University of Oxford will investigate how healthier, more sustainable diets can be achieved at population level, and how evidence can inform policy and practice across food, health and environmental systems.
The Department of Paediatrics at the University of Oxford has appointed Professor Isidro Cort\u00e9s-Ciriano as its first Little Princess Trust Professor of Paediatric Oncology, marking a major milestone in a partnership dedicated to accelerating the development of new treatments for children with cancer.
Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK\u2019s Advanced Research and Invention Agency (ARIA).
Researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, have developed a new calculator that estimates a person's risk of developing serious muscle disorders\u202ffrom statins. The tool could\u202fhelp patients and clinicians make more\u202finformed decisions about using these widely prescribed medications to prevent heart attacks and strokes.
Mr Keaton Jones, Senior Clinical Researcher at the Nuffield Department of Surgical Sciences, attended 'Driving Treatment Breakthroughs', a Pancreatic Cancer UK parliamentary reception held at the House of Commons on 16 June 2026.
Many congratulations to Anjali Hinch and Girish Mali in the Sir William Dunn School of Pathology for this prestigious honour, recognising researchers in the early years of establishing their groups.
The University of Oxford and King\u2019s College London (King\u2019s) have joined the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international collaboration of sites working together to accelerate clinical trial readiness and therapeutic development for autism through a large-scale natural history and clinical endpoint study.
![\"Young](\"https://www.medsci.ox.ac.uk/news/salsa-classes-shown-to-reduce-depressive-symptoms-in-young-adults/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n